We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Share News (BCN)

  • There is currently no data for BCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

Wed, 03rd Feb 2021 10:50

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Dr Martens, 452.16p, up 22% from initial public offering price of 370p. The iconic boot maker said its entire share capital has begun trading on London's Main Market on Wednesday, with a market value of around GBP4.5 billion putting Dr Martens easily in contention for a spot in the FTSE 250 index of mid-caps.

----------

Volution Group, up 5.5% at 308.57 pence, 12-month range 122.46p-313p. The ventilation products supplier said it is "pleased" with its strong trading performance and also has agreed to buy Swedish ventilation equipment maker Nordiska Klimatfabriken.

----------

STV Group up 5.0% at 347.56p, 12-month range, 210p-452.83p. The Glasgow-based television broadcaster said it saw a record-breaking performance in January for its free streaming service STV Player, with the release of exclusive drama box sets driving viewer growth. STV said total steams for STV Player are up over 100% to 12.5 million streams when compared to a year prior. The number of monthly active users on the service grew by 20% in January.

----------

Standard Life Investments Property, up 4.9% at 60.80p, 12-month range 43.51p-993p. The property investor said net asset value per share as at December 31 was up 4.1% to 82.0p from 78.8p.

----------

4D Pharma, up 4.6% at 120.83p, 12-month range 23.5p-183p. The pharmaceutical company said enrolment is progressing well both for part B of the MRx0518 and Keytruda combination study and for its pancreatic cancer study. 4D said 24 additional patients across five active US sites have been treated in part B of the study, consisting of 12 patients with renal cell carcinoma, 9 patients with non-small cell lung cancer, and 3 bladder cancer patients.

----------

SMALL-CAP - LOSERS

----------

Bacanora Lithium, down 15% at 47.40p, 12-month range 14.5p-69p. The lithium explorer said it successfully raised approximately USD65 million through the placing of shares as well as a retail offer. A total of 101.4 million shares were placed at 45 pence each, raising proceeds of about USD62 million, while an extra USD3 million was raised after retail and other investors subscribed for 5.6 million shares.

----------

Porvair, down 2.5% at 525.75p, 12-month range 370p-796.47p. The filtration, laboratory and environmental technology firm's shares were continuing to fall after it said earlier this week that near-term trading remains unpredictable and continued to withhold earnings guidance. The stock is down 8.4% since last Thursday.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Jan 2022 14:27

IN BRIEF: Bacanora Lithium delisting date nears amid Ganfeng takeover

IN BRIEF: Bacanora Lithium delisting date nears amid Ganfeng takeover

Read more
23 Dec 2021 21:13

IN BRIEF: Bacanora Lithium sets delisting date after Ganfeng takeover

IN BRIEF: Bacanora Lithium sets delisting date after Ganfeng takeover

Read more
20 Dec 2021 13:06

CORRECT(Dec 17): Bacanora Lithium takeover by Ganfeng unconditional

CORRECT(Dec 17): Bacanora Lithium takeover by Ganfeng unconditional

Read more
17 Dec 2021 21:23

IN BRIEF: Bacanora Lithium takeover by Ganfeng now unconditional

IN BRIEF: Bacanora Lithium takeover by Ganfeng now unconditional

Read more
12 Nov 2021 20:26

IN BRIEF: Ganfeng says Bacanora takeover backed by about 57%

IN BRIEF: Ganfeng says Bacanora takeover backed by about 57%

Read more
20 Oct 2021 19:28

IN BRIEF: Bacanora Lithium gains court approval for capital reduction

IN BRIEF: Bacanora Lithium gains court approval for capital reduction

Read more
20 Oct 2021 12:25

Bacanora Lithium capital reduction plans get court approval

(Sharecast News) - Bacanora Lithium said on Wednesday that its capital reduction plans had now been approved by the High Court, as it updated the market on the Sonora Project.

Read more
4 Oct 2021 22:00

TRADING UPDATES: Bacanora not worried of Mexico changes; Helios buys

TRADING UPDATES: Bacanora not worried of Mexico changes; Helios buys

Read more
4 Oct 2021 15:40

Bacanora reassures shareholders over proposed law in Mexico

(Sharecast News) - Lithium development company Bacanora updated the market in light on new legislation around lithium mining announced by the government of Mexico on Monday.

Read more
9 Sep 2021 11:33

EARNINGS UPDATES: STV, Chaarat, Sportech, Bacanora enter black

EARNINGS UPDATES: STV, Chaarat, Sportech, Bacanora enter black

Read more
25 Aug 2021 17:30

IN BRIEF: Bacanora agrees to GBP285 million Ganfeng takeover offer

IN BRIEF: Bacanora agrees to GBP285 million Ganfeng takeover offer

Read more
24 Aug 2021 15:59

Court finds against Bacanora in estate litigation

(Sharecast News) - Bacanora Lithium updated the market on its litigation with the estate of Colin Orr-Ewing over its challenge to the validity of the lithium royalty over the Sonora Lithium Project on Tuesday.

Read more
24 Aug 2021 12:35

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

Read more
8 Jul 2021 20:26

TRADING UPDATES: Bank of Georgia drops buffer; Sureserve nabs contract

TRADING UPDATES: Bank of Georgia drops buffer; Sureserve nabs contract

Read more
1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.